These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 23749687
1. Risk of subsequent malignancies in survivors of childhood leukemia. Perkins SM, Dewees T, Shinohara ET, Reddy MM, Frangoul H. J Cancer Surviv; 2013 Dec; 7(4):544-50. PubMed ID: 23749687 [Abstract] [Full Text] [Related]
2. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. MacArthur AC, Spinelli JJ, Rogers PC, Goddard KJ, Phillips N, McBride ML. Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718 [Abstract] [Full Text] [Related]
3. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Tracey E, Sankila R, Weiderpass E, Olsen JH, McBride ML, Brewster DH, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Merletti F, Boffetta P. J Natl Cancer Inst; 2007 May 16; 99(10):790-800. PubMed ID: 17505074 [Abstract] [Full Text] [Related]
4. Long-Term Risk of Subsequent Malignant Neoplasms Among Childhood and Adolescent Lymphoma Survivors (1975-2013): A Population-Based Predictive Nomogram. Liu J, Zheng Q, Beeraka NM, Zhang X, Li T, Song R, Zhao D, Fan R. Oncologist; 2023 Sep 07; 28(9):e765-e773. PubMed ID: 37177980 [Abstract] [Full Text] [Related]
5. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP. J Natl Cancer Inst; 2010 Jul 21; 102(14):1083-95. PubMed ID: 20634481 [Abstract] [Full Text] [Related]
6. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry. Rihani R, Bazzeh F, Faqih N, Sultan I. Cancer; 2010 Sep 15; 116(18):4385-94. PubMed ID: 20549819 [Abstract] [Full Text] [Related]
7. Evidence of high mortality in long term survivors of childhood medulloblastoma. Ning MS, Perkins SM, Dewees T, Shinohara ET. J Neurooncol; 2015 Apr 15; 122(2):321-7. PubMed ID: 25557108 [Abstract] [Full Text] [Related]
8. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. Essig S, Li Q, Chen Y, Hitzler J, Leisenring W, Greenberg M, Sklar C, Hudson MM, Armstrong GT, Krull KR, Neglia JP, Oeffinger KC, Robison LL, Kuehni CE, Yasui Y, Nathan PC. Lancet Oncol; 2014 Jul 15; 15(8):841-51. PubMed ID: 24954778 [Abstract] [Full Text] [Related]
9. Risk of second malignancies among survivors of pediatric thyroid cancer. Adly MH, Sobhy M, Rezk MA, Ishak M, Afifi MA, Shafie AE, Ali MA, Zekri W, Alfaar AS, Rashed WM. Int J Clin Oncol; 2018 Aug 15; 23(4):625-633. PubMed ID: 29492793 [Abstract] [Full Text] [Related]
10. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, Razzouk BI, Ribeiro RC, Rubnitz JE, Sandlund JT, Rivera GK, Evans WE, Relling MV, Pui CH. JAMA; 2007 Mar 21; 297(11):1207-15. PubMed ID: 17374815 [Abstract] [Full Text] [Related]
11. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup. Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, Fresneau B, Journy N, Morsellino V, Bárdi E, Bautz A, Byrne J, Feijen ELA, Teepen JC, Vu-Bezin G, Rubino C, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Hau EM, Jankovic M, Kaatsch P, Kaiser M, Linge H, Muraca M, Llanas D, Veres C, Øfstaas H, Diallo I, Mansouri I, Ronckers CM, Skinner R, Terenziani M, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuehni CE, Winther JF, Michel G, Kremer LCM, Hjorth L, Haddy N, de Vathaire F, Reulen RC. Eur J Cancer; 2019 Aug 21; 117():71-83. PubMed ID: 31260818 [Abstract] [Full Text] [Related]
12. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries. Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Olsen JH, Tracey E, Pukkala E, Weiderpass E, Brewster DH, Tamaro S, Chia KS, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Merletti F, Boffetta P. Int J Cancer; 2011 Oct 15; 129(8):1940-52. PubMed ID: 21520035 [Abstract] [Full Text] [Related]
13. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015. Turcotte LM, Liu Q, Yasui Y, Arnold MA, Hammond S, Howell RM, Smith SA, Weathers RE, Henderson TO, Gibson TM, Leisenring W, Armstrong GT, Robison LL, Neglia JP. JAMA; 2017 Feb 28; 317(8):814-824. PubMed ID: 28245323 [Abstract] [Full Text] [Related]
14. Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study. Dixon SB, Chen Y, Yasui Y, Pui CH, Hunger SP, Silverman LB, Ness KK, Green DM, Howell RM, Leisenring WM, Kadan-Lottick NS, Krull KR, Oeffinger KC, Neglia JP, Mertens AC, Hudson MM, Robison LL, Armstrong GT, Nathan PC. J Clin Oncol; 2020 Oct 10; 38(29):3418-3429. PubMed ID: 32706634 [Abstract] [Full Text] [Related]
15. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, Ribeiro RC, Relling MV, Kun LE, Evans WE, Hudson MM. N Engl J Med; 2003 Aug 14; 349(7):640-9. PubMed ID: 12917300 [Abstract] [Full Text] [Related]
16. Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia. Westerveld ASR, Roesthuis P, van der Pal HJH, Bresters D, Bierings M, Loonen J, de Vries ACH, Louwerens M, Koopman MMW, van den Heuvel-Eibrink MM, van der Heiden-van der Loo M, Hoogerbrugge P, Janssens GO, de Krijger RR, Ronckers CM, Pieters R, Kremer LCM, Teepen JC. Blood Cancer J; 2024 Aug 28; 14(1):150. PubMed ID: 39198413 [Abstract] [Full Text] [Related]
17. Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Chow EJ, Friedman DL, Stovall M, Yasui Y, Whitton JA, Robison LL, Sklar CA. Pediatr Blood Cancer; 2009 Sep 28; 53(3):432-7. PubMed ID: 19459201 [Abstract] [Full Text] [Related]
18. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati-Bellani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT, Late Effects Study Group. J Clin Oncol; 2003 Dec 01; 21(23):4386-94. PubMed ID: 14645429 [Abstract] [Full Text] [Related]
19. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. Olsen JH, Möller T, Anderson H, Langmark F, Sankila R, Tryggvadóttír L, Winther JF, Rechnitzer C, Jonmundsson G, Christensen J, Garwicz S. J Natl Cancer Inst; 2009 Jun 03; 101(11):806-13. PubMed ID: 19470947 [Abstract] [Full Text] [Related]
20. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Pappo AS, Armstrong GT, Liu W, Srivastava DK, McDonald A, Leisenring WM, Hammond S, Stovall M, Neglia JP, Robison LL. Pediatr Blood Cancer; 2013 Mar 03; 60(3):461-6. PubMed ID: 22887858 [Abstract] [Full Text] [Related] Page: [Next] [New Search]